Serial Number | 98458758 |
Word Mark | COSMOFED |
Filing Date | Wednesday, March 20, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Wednesday, October 30, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 19, 2024 |
Goods and Services | Pharmaceutical preparations for the treatment and prevention of iron deficiency, anaemia, and iron overload in humans; iron preparations for pharmaceutical use being nutritional supplements; iron preparations for pharmaceutical use for treating iron deficiency in humans |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 20, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Pharmacosmos Holding A/S |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Holbæk DK-4300 DK |
Event Date | Event Description |
Wednesday, March 20, 2024 | NEW APPLICATION ENTERED |
Tuesday, April 2, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sunday, September 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Sunday, September 29, 2024 | NON-FINAL ACTION WRITTEN |
Sunday, September 29, 2024 | NON-FINAL ACTION E-MAILED |
Monday, October 21, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, October 21, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, October 21, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, October 24, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, September 27, 2024 | ASSIGNED TO EXAMINER |